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INTRODUCTION: Deep sternal wound infection is a life-threatening complication of longitudinal median
sternotomy with extensive loss of sternal bone tissue and adjacent ribs. Wound dehiscence cases with no
loss of bone tissue can be resolved via osteosynthesis using titanium plates. Unfortunately, this cannot be
used in cases of massive bone tissue loss defects due to insufﬁcient support for ﬁxing the plate material
caused by missing bone surface which increasing the risk of osteosynthesis failure. We describe the
treatment outcome of sternal dehiscence with massive bone tissue loss defects using an allogenous
sternal bone graft.
CASE PRESENTATION: A 62 year old diabetic female was operated for serious sternotomy dehiscence after
surgery for aortic valve replacement. There was bone tissue loss and complications. We used allogenous
sternal bone graft to close the wound. To monitor the healing of the graft, we performed SPECT/CT
examinations of anterior chest wall. We describe the successful healing of the graft with the reduction
of defects in osteoblastic activity by 42% 21 months after the graft implantation. The wound was found
to be healed on all examinations, The chest wall is stable and the patient reports a good life quality.
DISCUSSION: An allogenous bone transplant contains no vital bone marrow cells, which eliminates
immuno-genetic graft rejection by the patient. Signiﬁcant osteoblastic activity was thus registered,
especially in places where crushed spongy bone had been applied.
CONCLUSIONS: Transplantation of allogenous bone graft sternum in our experience is the best option for
treating extensive post-sternotomy defects.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Longitudinal median sternotomy is the most commonly used
operating approach in cardiac surgery. However, early complica-
tions along with the development of deep sternal wound infection
(DSWI), possibly accompanied by extensive loss of sternal bone tis-
sue and adjacent ribs, remain a life-threatening complication of the
primary surgery. Besides the risk of injury to the exposed right ven-
tricle and the sewn aorto-coronary bypasses, the patient is at risk
of respiratory insufﬁciency due to instability of the chest wall. The
unstable base of the skeleton is also a source of further difﬁculties
in the healing of subcutaneous tissue and skin.
Wound dehiscence cases with no loss of bone tissue can be
resolved using AO osteosynthesis titanium plates. Unfortunately,
this method cannot be used to restore the stability of the chest
wall in cases of massive bone tissue loss defects. There is insufﬁ-
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cient support for ﬁxing material of the plates caused by the missing
bone surface which increases the risk of osteosynthesis failure.
Based on the experience of orthopaedic surgery we have been
using allogenous bone grafts in these situations. Described below
are the three year results of treating massive post-sternotomy
defects of the sternum using these grafts.
2. Case presentation
A 69-year-old female patient, an obese diabetic with a body
mass index (BMI) of 31, primarily operated for aortic valve replace-
ment with a mechanical prosthesis in January 2012, was twice
revised within a week after the primary surgery. A serious ster-
notomy dehiscence with loss of bone tissue of the sternum and
partial loss of bone tissue of ribs developed, along with a Staphy-
lococcus epidermidis infection in the wound. This was managed in
ﬁve sessions of vacuum assisted closure (V.A.C) treatment and a
targeted antibiotic therapy recommended by the Antibiotic Centre.
To close the wound, allogenous sternal bone graft was used and
ﬁxed using AO osteosynthesis titanium plates (Fig. 1.).
http://dx.doi.org/10.1016/j.ijscr.2014.12.027
2210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Application of allogenous sternal bone graft and its ﬁxing using titanium
plates.
Prior to the implantation of the graft, it was necessary to release
the pectoral musculocutaneous ﬂaps from the skeleton rib cage to
the level of the midclavicular line. The basic surgical technique was
modiﬁed by a more aggressive debridement of residual chest bone
or ribs (1–2 cm safety line). Afterwards, the bone graftwas adjusted
to the size of the bone defect andﬁxedwith plates anchored by self-
cutting or self-drilling cortical screws. The lines of contact between
the graft and recipient tissues were ﬁlled with crushed spongy
bone prepared from an allogenous femoral graft. Two subpectoral
redon drains were inserted for seven days. Soft tissues were closed
by direct suture of the subcutaneous tissue and skin. Within the
postoperative period, we was strongly recommended avoidance of
excessive coughing or any rough mechanical strain on the ster-
nal wall. Antibiotics were administered for three weeks after the
surgery.
Postoperativemonitoringwas carried out during regular clinical
examination visits 3, 6 and 12 months after surgery and then once
a year. The wound had healed on all occasions, the chest wall was
stable, the patient had no emphysema and her upper limb mobility
was not limited.
In the context of the long-term monitoring, in addition to rou-
tine clinical examinations, a planar whole-body bone scan with
SPECT/CT of the thorax was performed following the administra-
tion of 750MBq Technetium 99m-bisphosphonate on a GE Inﬁnia
Hawkey gamma camera equipped with low-energy, high reso-
lution parallel-hole collimators. Planar images were acquired in
1024×256 matrix. SPECT data with low-dose CT for attenua-
tion correction and morphological correlation were acquired in
128×128 matrix.
Planar anterior whole-body (left view in Fig. 2A,B,C) and SPECT
(right view in Fig. 2A,B,C) images performed 3 months after graft
implantation, showed a central photon-deﬁcient area with sur-
rounding tracer uptake (Fig. 2A). Images obtained 21 months after
surgery showed improvement of tracer uptake to the full within
the sternal manubrium, and partial uptake in the sternal cor-
pus (Fig. 2B). Quantitatively, a photon-deﬁcient area measured
as a region of interest (ROI) reduced to 58% - from 1440mm2 to
835mm2 (Fig. 2C).
3. Discussion
Median sternotomy is hils themost common incisionperformed
in cardiosurgery due to its technical simplicity and excellent expo-
sure of the heart, great vessels and pulmonaryhils [1].
Wire re-cerclage was a commonly used method for addressing
sternal approximation in patients with sternal dehiscence after
DSWI. However, the quality of residual sternal bone or its loss
makes re-cerclage troublesome or even risky for achieving sternal
stability. The occurrence of extensive adhesions below the sternum
in DSWI patients increases the risk of damage to the right ven-
tricle and bypass grafts when peri-, trans- and parasternal wiring
techniques are used [2–4].
Non-complicated sternal dehiscence followingDSWI can be sta-
bilized with transverse titanium plates (Titanium Sternal Fixation
systemTM, DePuy- Synthes). Chest stability after a healed DSWI
improves respiratory function, augmentswoundhealingprocesses,
shortens in-hospital stay, and improves patient life quality [5–7].
Unfortunately, thismethod cannot be used in cases ofmassive bone
tissue loss defects. Insufﬁcient support for ﬁxing material of the
plates caused by the missing bone surface increases the risk of fail-
ure of osteosynthesis. Shear forces may loosen screws and threaten
stability [8].
A conventional surgical approach to manage the large residual
bone defect leaves the sternotomy wound unstable and employs
the greater omentum or a muscle ﬂap to ﬁll any dead spaces. This
approach resulted in sternal instability and ﬂap-related morbidity
even when wounds were well-healed [9,10].
Some case reports have included the use of an autologous bone
iliac crest graft or allogenous ﬁbula graft to supply residual bone
defects after DSWI [11,12]. Use of an allogenous sternocostal bone
graft for sternal reconstruction after chondrosarcoma removal was
also reported [13]. The sternal allograft transplantation with no
wound healing complications has been described an alternative for
chest wall reconstruction [14,15].
Treatment of massive bone loss after DSWI using an allogenous
bone graft to ﬁll in the sternal defect and ﬁxing the sternum with
a titanium plate system ensures stability of chest cage stability. An
allogenous bone transplant contains no vital bone marrow cells,
which eliminates difﬁculties with immuno-genetic acceptance of
the graft by a patient; it is a biological tissue transfer, which even
under conditions of maximum precautions poses a minor risk for
transmission of viral and bacterial infections.
Strict absence of early microbial infection is an essential con-
dition for the implantation of the graft. In our department, an
established wound care protocol with the use of V.A.C. has been
used on a long-term basis [16]. Bandage changes are performed
under general anaesthesia in the operating room. During each ban-
dagechangesession,devitalized lines/bordersof edgesofbonesand
soft tissues are radically removed. Superﬁcial wound swabs, sam-
ples of bone and cartilage fragments collected during each bandage
change are sent formicrobiological examination in order to achieve
three consecutive negative results. Only then the patient is indi-
cated for implantation of an allogenous bone graft. The informed
consent of the patient is an indispensable part of the process.
An allogenous graft must meet the legislative criteria of the
Czech Republic and the European Association of Tissue Banks
[17,18]. Prior to graft harvesting, each donor is cross-checked for
registration within the national registry for organ donation refusal.
All deceaseddonors treated for infectiousdisease, sepsis,malignant
tumours, or systemic and autoimmunediseases at the timeof death
are withdrawn from the donor list. Donor blood serum samples are
tested for antibodies and HIV types 1 and 2, hepatitis B surface
antigen (HbsAg), hepatitis C antibodies (anti-HCV), and HTLV I and
II antibodies. Harvest of a sternal bone graft is performed under
strictly sterile conditions by a team from the National Cell and Tis-
sue Centre in Brno. The graft is harvested under sterile conditions
and stored in the freezer at −80 ◦C. Prior to its clinical use, the graft
is thawed at 4–6 ◦C for 12h, soaked with a 1% gentamicin solu-
tion, prepared for its ﬁnal shape, and stored in the freezer again at
−80 ◦C. If bacterial sampling is negative, the graft is thawed for 12h
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Fig. 2. (A) Planar anterior whole-body (left) and SPECT (right) images 2 months after graft implantation. Central photon-deﬁcient area with surrounding tracer uptake. (B)
Check examination 21 months after graft implantation–improvement of tracer uptake (full in manubrium sterni, partially in corpus sterni). (C) Quantitatively 21 months
after. A photon-deﬁcient area measured as a region of interest (ROI) reduced to 58%.
before transplantation, and submerged in a bath with 1% neomycin
solution immediately before surgery.
Drawing on the basis of references in the ﬁeld of orthopaedic
surgery, we have chosen SPECT/CT of the chest wall to moni-
tor the activity of healing of the graft administering Technetium
99m-bisphosphonate whose penetration into bone tissue enables
accurate assessment of osteoblast metabolism [19]. Examination
conﬁrmedsuccessfulhealingof thegraft alongwith reductionof the
defect in osteoblastic activity. Signiﬁcant osteoblastic activity was
then registered, especially in places where crushed bone spongy
bone had been applied which veriﬁed its superior healing effect.
4. Conclusion
Since 2012 to date,we have performed a total of nine allogenous
sternal graft transplantations. Monitoring of the case described
took place over three years. The patient reports a consistently high
quality of life.
Radical debridement of thewound edges and recurring negative
results of microbial examination of bone fragments are fundamen-
tal principles of this method. A vital factor in the healing of bone
tissue is adequate plate ﬁxation of the graft to the outside of the
skeleton ribcage. Crushed spongyboneapplied to the lineof contact
between the graft and recipient tissues also demonstrated great
healing efﬁcacy.
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